The Generalized Aminoaciduria Seen in Patients With Hepatocyte Nuclear Factor-1α Mutations Is a Feature of All Patients With Diabetes and Is Associated With Glucosuria

  1. Coralie Bingham1,
  2. Sian Ellard1,
  3. Anthony J. Nicholls2,
  4. Charles A. Pennock3,
  5. John Allen3,
  6. Alan J. James2,
  7. Simon C. Satchell2,
  8. Maurice B. Salzmann2 and
  9. Andrew T. Hattersley1
  1. 1Department of Vascular Medicine and Diabetes Research, School of Postgraduate Medicine and Health Sciences, University of Exeter, Devon, U.K.
  2. 2Royal Devon and Exeter Healthcare NHS Trust, Barrack Road, Exeter, U.K.
  3. 3Lewis Laboratory, Southmead Hospital, Westbury-On-Trym, Bristol, U.K.

    Abstract

    Hepatocyte nuclear factor-1α (HNF-1α) mutations are the most common cause of maturity-onset diabetes of the young. HNF-1α homozygous knockout mice exhibit a renal Fanconi syndrome with glucosuria and generalized aminoaciduria in addition to diabetes. We investigated glucosuria and aminoaciduria in patients with HNF-1α mutations. Sixteen amino acids were measured in urine samples from patients with HNF-1α mutations, age-matched nondiabetic control subjects, and age-matched type 1 diabetic patients, type 2 diabetic patients, and patients with diabetes and chronic renal failure. The HNF-1α patients had glucosuria at lower glycemic control (as shown by HbA1c) than type 1 and type 2 diabetic patients, consistent with a lower renal glucose threshold. The HNF-1α patients had a generalized aminoaciduria with elevated levels of 14 of 16 amino acids and an increased mean Z score for all amino acids compared with control subjects (0.66 vs. 0.00; P < 0.0005). Generalized aminoaciduria was also present in type 1 diabetic (Z score, 0.80; P < 0.0001), type 2 diabetic (Z score, 0.71; P < 0.0002), and chronic renal failure (Z score, 0.65; P < 0.01) patients. Aminoaciduria was not associated with microalbuminuria or proteinuria but was associated with glucosuria (1.00 glucosuria vs. 0.19 no glucosuria; P = 0.002). In type 1 diabetic patients, urine samples taken on the same day showed significantly more aminoaciduria when glucosuria was present compared with when it was absent (P < 0.01). In conclusion, HNF-1α mutation carriers have a mutation-specific defect of proximal tubular glucose transport, resulting in increased glucosuria. In contrast, the generalized aminoaciduria seen in patients with HNF-1α mutations is a general feature of patients with diabetes and glucosuria. Glucose may depolarize and dissipate the electrical gradient of the sodium-dependent amino acid transporters in the proximal renal tubule, causing a reduction in amino acid resorption.

    Footnotes

    • Address correspondence and reprint requests to Prof. Andrew Hattersley, Department of Diabetes and Vascular Medicine, School of Postgraduate Medicine and Health Sciences, Barrack Road, Exeter EX2 5AX, Devon, U.K. E-mail: A.T.Hattersley{at}exeter.ac.uk.

      Received for publication 12 January 2001 and accepted in revised form 21 May 2001.

      HNF-1α, hepatocyte nuclear factor-1α; MODY, maturity-onset diabetes of the young; SGLT-2, sodium-glucose transporter-2.

    « Previous | Next Article »Table of Contents